1. Home
  2. SCLXW vs FCNCP Comparison

SCLXW vs FCNCP Comparison

Compare SCLXW & FCNCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLXW
  • FCNCP
  • Stock Information
  • Founded
  • SCLXW N/A
  • FCNCP N/A
  • Country
  • SCLXW United States
  • FCNCP United States
  • Employees
  • SCLXW 113
  • FCNCP 16021
  • Industry
  • SCLXW Biotechnology: Pharmaceutical Preparations
  • FCNCP Major Banks
  • Sector
  • SCLXW Health Care
  • FCNCP Finance
  • Exchange
  • SCLXW Nasdaq
  • FCNCP Nasdaq
  • Market Cap
  • SCLXW N/A
  • FCNCP N/A
  • IPO Year
  • SCLXW 2021
  • FCNCP N/A
  • Fundamental
  • Price
  • SCLXW $0.24
  • FCNCP $22.06
  • Analyst Decision
  • SCLXW
  • FCNCP
  • Analyst Count
  • SCLXW 0
  • FCNCP 0
  • Target Price
  • SCLXW N/A
  • FCNCP N/A
  • AVG Volume (30 Days)
  • SCLXW N/A
  • FCNCP N/A
  • Earning Date
  • SCLXW N/A
  • FCNCP N/A
  • Dividend Yield
  • SCLXW N/A
  • FCNCP N/A
  • EPS Growth
  • SCLXW N/A
  • FCNCP N/A
  • EPS
  • SCLXW N/A
  • FCNCP N/A
  • Revenue
  • SCLXW N/A
  • FCNCP N/A
  • Revenue This Year
  • SCLXW N/A
  • FCNCP N/A
  • Revenue Next Year
  • SCLXW N/A
  • FCNCP N/A
  • P/E Ratio
  • SCLXW N/A
  • FCNCP N/A
  • Revenue Growth
  • SCLXW N/A
  • FCNCP N/A
  • 52 Week Low
  • SCLXW N/A
  • FCNCP N/A
  • 52 Week High
  • SCLXW N/A
  • FCNCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • SCLXW N/A
  • FCNCP 43.49
  • Support Level
  • SCLXW N/A
  • FCNCP $21.62
  • Resistance Level
  • SCLXW N/A
  • FCNCP $22.53
  • Average True Range (ATR)
  • SCLXW 0.00
  • FCNCP 0.55
  • MACD
  • SCLXW 0.00
  • FCNCP -0.02
  • Stochastic Oscillator
  • SCLXW 0.00
  • FCNCP 26.51

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About FCNCP First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank & Trust Company. FCB was founded as the Bank of Smithfield in North Carolina and has expanded through both de novo branching and acquisitions. FCB currently operates in nearly half of the continental United States, but principally takes deposits in the Carolinas. The bank's operations have historically been influenced by the Holding family, which has traditionally held executive and director positions, as well as controlling a large percentage of its outstanding stock. FCB provides a wide range of retail and commercial banking services, including traditional lending and deposit-taking, as well as trust and wealth management. FCB's main source of revenue is net interest income.

Share on Social Networks: